Codman announces European launch of next generation Revive SE for acute ischaemic stroke treatment at ESMINT


The new version of the Revive SE thrombectomy device offers enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischaemic stroke. The announcement was made at the 5th Congress of European Society of Minimally Invasive Neurological Therapy (ESMINT) in Nice, France.

The Revive SE device is a self-expanding basket made out of nitinol that features a closed-ended soft distal tip to capture clots and large fragments with minimal trauma. It is designed with narrower and taller struts than similar devices on the market to better penetrate and engage more clot and lower the force required to pass the device through a 0.021 micro-catheter. The Revive SE device may also be used for the non-surgical removal of thrombi and emboli with aspiration and injected contrast agents.

“Our experience with the device has been excellent,” said Stefan Rohde, head of the Department of Radiology and Neuroradiology, Klinikum Dortmund, Germany. “We are achieving consistently good recanalisation rates and the enhanced navigation eases passage through the cerebral vasculature to the thrombus, which is very important in a time-sensitive operation of this kind.”

CE marking for the latest Revive SE device was obtained in June 2013. Several institutions in Germany, France, Italy, UK, Portugal, Spain, Belgium, the Netherlands, Israel, Denmark, Slovakia and Turkey have already begun using the device. The Revive SE device is not currently approved for distribution in the USA.

“Feedback throughout Europe has been very positive and we are seeing great interest in the Revive SE device at ESMINT,” said P Laxmin Laxminarain, worldwide president of Codman Neuro. “We believe the device will become an increasingly important treatment option for ischaemic stroke patients at institutions throughout Europe.”